Literature DB >> 10092596

A mechanistic study of self-inactivation of the peroxidase activity in prostaglandin H synthase-1.

G Wu1, C Wei, R J Kulmacz, Y Osawa, A L Tsai.   

Abstract

Prostaglandin H synthase (PGHS) is a self-activating and self-inactivating enzyme. Both the peroxidase and cyclooxygenase activities have a limited number of catalytic turnovers. Sequential stopped-flow measurements were used to analyze the kinetics of PGHS-1 peroxidase self-inactivation during reaction with several different hydroperoxides. The inactivation followed single exponential kinetics, with a first-order rate constant of 0.2-0.5 s-1 at 24 degrees C. This rate was independent of the peroxide species and concentration used, strongly suggesting that the self-inactivation process originates after formation of Compound I and probably with Intermediate II, which contains an oxyferryl heme and a tyrosyl radical. Kinetic scan and rapid scan experiments were used to monitor the heme changes during the inactivation process. The results from both experiments converged to a simple, linear, two-step mechanism in which Intermediate II is first converted in a faster step (0.5-2 s-1) to a new compound, Intermediate III, which undergoes a subsequent slower (0.01-0.05 s-1) transition to a terminal species. Rapid-quench and high pressure liquid chromatography analysis indicated that Intermediate III likely retains an intact heme group that is not covalently linked with the PGHS-1 protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092596     DOI: 10.1074/jbc.274.14.9231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Oxyferryl heme and not tyrosyl radical is the likely culprit in prostaglandin H synthase-1 peroxidase inactivation.

Authors:  Gang Wu; Corina E Rogge; Jinn-Shyan Wang; Richard J Kulmacz; Graham Palmer; Ah-Lim Tsai
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

Review 3.  Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Authors:  Daniel J Hermanson; Joyonna C Gamble-George; Lawrence J Marnett; Sachin Patel
Journal:  Trends Pharmacol Sci       Date:  2014-05-18       Impact factor: 14.819

4.  Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.

Authors:  Maria G Sciulli; Francesca Seta; Stefania Tacconelli; Marta L Capone; Emanuela Ricciotti; Giuseppa Pistritto; Paola Patrignani
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

5.  Suicide inactivation of MauG during reaction with O(2) or H(2)O(2) in the absence of its natural protein substrate.

Authors:  Sooim Shin; Sheeyong Lee; Victor L Davidson
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

6.  In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors.

Authors:  Elena B Okon; Ali Golbabaie; Cornelis van Breemen
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  Inhibition of cyclooxygenases 1 and 2 by the phospholipase-blocker, arachidonyl trifluoromethyl ketone.

Authors:  H J Leis; W Windischhofer
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

Review 8.  Prostaglandin H synthase: resolved and unresolved mechanistic issues.

Authors:  Ah-Lim Tsai; Richard J Kulmacz
Journal:  Arch Biochem Biophys       Date:  2009-09-01       Impact factor: 4.013

9.  Structural basis for certain naturally occurring bioflavonoids to function as reducing co-substrates of cyclooxygenase I and II.

Authors:  Pan Wang; Hyoung-Woo Bai; Bao Ting Zhu
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

Review 10.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.